Purpose: Liver metabolism plays a pivotal role in the development of metabolic disorders. We aimed to investigate the clinical and laboratory risk factors associated with alanine aminotransferase (ALT) levels in young adolescents from an urban population in Korea. Methods: A population of 120 apparently healthy adolescents aged 12-13 years was included in the cross-sectional design study; 58 were overweight or obese and 62 were of normal weight. We estimated anthropometric and laboratory measurements, including waist-to-height ratio, blood pressure, insulin sensitivity, aspartate aminotransferases (AST), ALT, and lipid profiles. Results: The mean ages of the overweight or obese and normal weight participants were 12.9±0.3 and 13.0±0.3 years, respectively. Height, weight, body mass index, waist circumference, waist-to-height ratio, systolic and diastolic blood pressure, AST, ALT, total cholesterol, low-density lipoprotein-cholesterol, triglyceride, insulin, and the homeostatic model assessment of insulin resistance (HOMA-IR) score were significantly higher and the high-density lipoprotein-cholesterol and quantitative insulin-sensitivity check index were significantly lower in the overweight/obese participants in comparison to the normal-weight participants (all P<0.05). In multivariate linear regression analysis, waist-to-height ratio, systolic blood pressure, and HOMA-IR score were independently and positively associated with serum ALT levels. Conclusion: Screening for ALT levels in adolescents may help to differentiate those at risk of metabolic abnormalities and thus prevent disease progression at an early age.
Introduction
Obesity has emerged as a large public health concern and is now developing at younger ages around the world. 1) Mounting evidence reports that childhood obesity frequently continues into adulthood and causes the risk of various diseases, such as cardiovascular diseases, diabetes mellitus, and nonalcoholic fatty liver disease (NAFLD), ultimately leading to increased morbidity and mortality. 2) NAFLD is at present the most common cause of liver diseases among children and adole scents. 3, 4) With the surging epidemic of childhood and adolescent obesity, NAFLD is recognized as a major health threat in young generations. Previous studies have indicated that NAFLD is the hepatic manifestation of overweight, 5) obesity, 6) and metabolic syndrome. 6, 7) Although several studies 810) have investigated the risk of NAFLD among particular pediatric and adole scent groups, there have been scanty studies determining the risk factors associated with this
Laboratory analyses for obesity-related biomarkers
After a 12hour overnight fast, blood specimens were attained from the antecubital vein of the participants by venipuncture and were promptly centrifuged, aliquoted, and frozen at 20°C. The frozen serum and plasma samples were accumulated at 80°C until final analysis. Fasting plasma glucose, total cholesterol, triglyceride, and highdensity lipoproteincholesterol (HDLC) levels were quantified by enzymatic methods using a Hitachi Modular D2400 automated chemistry analyzer (Hitachi, Tokyo, Japan). Levels of lowdensity lipoproteincholesterol (LDLC) were determined using the following equation: LDLC=total cholesterol − HDLC − (triglyceride/5). Fasting insulin concentrations were assessed using a chemiluminescent microparticle immunoassay (Abbott Architect System, Irving, TX, USA). We also subjected the fasting data to various transformations and ultimately defined quantitative insulin sensitivity check index (QUICKI=1/[log(I 0 )+log(G 0 )]), where I 0 is the fasting insulin, and G 0 is the fasting glucose. Insulin resistance was computed using the homeostatic model assessment of insulin resis tance (HOMAIR) and assessed using the following formula: HOMA IR=(fasting insulin [μIU/mL]×fasting glucose [mg/dL]/18)/22.5.
16)

Serum AST and ALT measure ment
Serum aspartate aminotransferases (AST) and ALT levels were measured by the catalytic con centration from the rate of decrease of nicotinamide adenine dinu cleotide measured at 340 nm by means of lactate dehydrogenase coupled reaction.
Statistical analysis
The normality of continuous variables was evaluated by the KolmogorovSmirnov test. All continuous variables are presented as mean±standard deviation, median (interquartile range), or are displayed as scatter plots. Comparisons of group differences for conti nuous variables were tested by the MannWhitney U test or the Student t test. Categorical variables are shown as an absolute num ber with the corresponding proportion. The significance of differences in proportions was assessed by the chisquare test. Spear man correlation analysis was implemented to determine the as sociation between serum ALT concentrations and anthropometric mea surements and obesityassociated biomarkers. The study sub jects' anthropometric and biochemical parameters with regards to ALT quartiles were computed using the analysis of variance for continuous variables and the chisquare test for categorical variables. ALT quartiles were classified separately as follows: Q1, ≤10.0; Q2, 10.0-13.0; Q3, 13.0-20.0; and Q4, ≥20.0. To determine independent correlates of serum ALT concentrations, a multivariate linear re gression analysis was utilized with the ALT level as the dependent variable. All statistical analyses were performed using IBM SPSS Sta tistics ver. 23.0 (IBM Co., Armonk, NY, USA). All statistical tests were 2sided, with a P value of <0.05 indicating statistical significance.
disorder. The lack of data hinders our ability to establish effective and appropriate primary prevention programs and services for young generations at risk of developing liver diseases and obesity associated disorders. If undiagnosed and untreated, NAFLD in children and adolescents may progress silently and ultimately lead to liver cirrhosis, portal hypertension, and liverrelated death in early adulthood. 11) In many countries, liver cirrhosis and other liver diseases are one of the main causes of general mortality and death among adults. 1214) Determining ways to differentiate subjects at risk of developing NAFLD may be critical to help reduce the burden of liver disease in adolescents. The current research aimed to determine whether there are differ ences in serum alanine aminotransferase (ALT) levels between over weight/obese subjects and normalweight subjects and to identify risk factors associated with ALT concentrations among apparently healthy young adolescents.
Materials and methods
Study subjects
One hundred and fiftyone adolescents aged 12-13 years per formed Student Health Examinations at a local health checkup clinic in Seoul, Korea between June and August 2015. Subjects who met the following exclusion criteria were not included in the analysis (n=31): any missing covariate data; a medication history of steroids, insulin, glucose regulators, or antihypertension medica tions; participants who refused the anthropometric measurements or blood test; participants who had signs and/or symptoms of acute infections; or participants who had not fasted for a minimum of 12 hours before blood test. After these exclusions, 120 adolescents (69 boys and 51 girls) were included in the final investigation. Health checkups were conducted by a single pediatrician in accordance with a systematized process. Body weight and height were quanti fied to the nearest 0.1 kg and 0.1 cm, respectively, with an automatic height-weight scale while the study participants wore light indoor clothing and no shoes. Body mass index (BMI) was computed as weight (kg)/height (m 2 ). The BMI percentiles for age and sex were calculated according to the 2017 Korea Growth Charts.
15) The parti cipants were categorized into 2 groups according to their BMI (i.e., overweight/obese and normalweight participants). A certified technician measured blood pressure (BP) a maximum of three times on the right arm with the participants seated after a 5minute rest using an automatic BP recorder. The development of secondary sexual characteristics was measured in accordance with Tanner stages by the pediatrician. The institutional review board of the CHA Gangnam Medical Center approved the study (IRB No. GCI115 04) and written informed consent was attained from guardians and consent/assent from the adolescents.
Results
Characteristics of the study participants
There were 58 subjects with overweight/obesity and 62 with normalweight, respectively (12.9±0.3 years vs. 13.0±0.3 years, P=0.11) ( Table 1 ). There were more boys in the overweight/obese subjects than in the normalweight subjects (P=0.037) ( Table 1 ).
Comparison of clinical and laboratory parameters between
overweight/obese and normal-weight subjects Table 1 indicates the comparison of the clinical and laboratory parameters for overweight/obese and normalweight subjects. In the anthropometric measurements, height, weight, BMI, waist cir cumference, waisttoheight ratio, and systolic and diastolic BP were significantly higher in the overweight/obese subjects in comparison with normalweight subjects (all P<0.05). There were no significant differences in age or Tanner stages between groups. In the laboratory parameters, AST, ALT, total cholesterol, LDLcholesterol, triglyceride, fasting insulin, and HOMAIR were significantly higher and HDL cholesterol and QUICKI were significantly lower in the overweight/ obese subjects when compared with normalweight subjects. There was no difference in fasting glucose between groups.
3. Associations of serum ALT levels with anthropometric measurements and obesity-related biomarkers
Spearman correlation results between ALT and various parame ters are depicted in Table 2 Korean J Pediatr 2019;62(2):48-54 regression analysis, waisttoheight ratio, systolic BP, and HOMAIR were independently and positively associated with serum ALT levels ( Table 4 ).
Discussion
The current study examined whether there are differences in serum ALT concentrations between overweight/obese and normal weight subjects and to differentiate risk factors associated with ALT concentrations among apparently healthy young adolescents. We found a significant difference in serum ALT levels between over weight/obese and normalweight subjects and a significant posi tive correlation between serum ALT levels and waisttoheight ratio, systolic BP, and HOMAIR in a multivariate linear regression analy sis. To the best of our knowledge, this is the first study to determine a significant positive association between ALT concen trations and waisttoheight ratio, systolic BP, and HOMAIR in a population of apparently healthy young adolescents.
The prevalence of obesity and obesityrelatedmetabolic disorders are on the rise across the globe. 1) Despite vigorous research effort, the pathogeneses and pathophysiology of these complex diseases remain elusive. In recent times, previous studies have reported that obese children and adolescents have higher serum ALT levels than controls, indicating that ALT may be implicated in the pathogenesis of obesity. A recent representative study of 1,262 participants aged 8-19 years in Mexico has reported that overweight and obese youth have higher serum ALT concentrations than controls and that abdominal obesity and insulin resistance are associated with an increased risk of elevated ALT (>40 U/L). 17) Another study com prising 5,586 adolescents aged between 12 and 19 years in the U.S. National Health and Nutrition Examination Survey 1999-2004 has reported that ALT level is associated with waist circumference and insulin resistance. 18) Recently, a representative study of 886 subjects with the mean age of 15 years in the 2009-2010 Korea National Health and Nutrition Examination Survey has shown that boys with the highest ALT quartile were more likely to have the highest quartile of insulin resistance. 19) In agreement with previous studies, the present study determined significantly increased serum ALT concentrations in adolescents with overweight/obesity than those of normalweight. In addition, we found a significant positive correlation between ALT and waisttoheight ratio, systolic BP, and HOMAIR, even after adjustment for potential confounders. Taken together, these findings indicate that measurement of serum ALT concentrations may provide clinicians with a useful biochemical marker for apparently healthy young adolescents at risk of metabo lic deregulations. Emerging evidence has indicated that the liver metabolism is implicated in the pathogenesis of metabolic syndrome 20) and in sulin resistance. 18, 20) NAFLD is the accumulation of large droplets of triglycerides in liver cells without a history of chronic alcohol consumption and, therefore, has been recognized as the hepatic manifestation of overweight, 5) obesity, 6) and metabolic syndrome. 6, 7) Despite the fact that liver biopsy is the gold standard for establishing NAFLD, serum biomarkers, particularly ALT levels, have been demonstrated to be highly precise in diagnosing NAFLD. These biomarkers are also well correlated with risk of overweight, obe sity, metabolic syndrome, diabetes mellitus, and cardiovascular disease. 7, 21, 22) Furthermore, previous research have demonstrated that the liver enzymes levels rise prior to the development of nonalcoholic fatty liver, proposing that liver enzymes may be a surrogate marker of NAFLD. 6, 7, 20, 23) Although we did not conduct a liver biopsy study, we found that the serum ALT levels were significantly and posi tively associated with abdominal obesity estimated using the waist Korean J Pediatr 2019;62(2):48-54 toheight ratio and certain metabolic risk factors including BP and insulin resistance estimated using the HOMAIR in a group of apparently healthy young adolescents in the multivariate linear regression analysis. There may be congruent metabolic mechanisms to consider as to why serum ALT is positively associated with waisttoheight ratio and certain metabolic risk factors. One possible underlying mecha nism for the current finding is as follows. ALT is a liver en zyme that is released in serum as a consequence of hepatocyte damage. If the aggregation of body fat becomes overloaded, adipose tissue releases free fatty acid into the hepatic portal vein; conse quently, this restricts the physiological measure of eradicating insulin resistance. Insulin resistance is known to increase uptake of free fatty acid into liver, and the absorbed hepatic fatty acid is resynthesized into triglyceride, ultimately leading to the development of NAFLD with ALT elevation. 24, 25) In this regard, several researchers have suggested that ALT elevation and/or NAFLD may be a hepatic com ponent of metabolic syndrome. 6, 7) In the present study, we used waisttoheight ratio instead of BMI in order to determine the association of ALT with anthropometric measures due to the fact that in the current study, ALT level showed a higher correlation coefficient with waisttoheight ratio (rho= 0.66, P<0.001) than BMI (rho=0.579, P<0.001). In this respect, there are studies suggesting that waisttoheight ratio is more useful in screening for cardiovascular risk factors in children and adoles cents.
2629) This measure is much easier to calculate than BMI, does not require sophisticated tables, and can be utilized to deter mine visceral obesity, even in normalweight subjects. 30) In addition, waisttoheight ratio integrates waist circumference as a measure of abdominal obesity and adjusts for a subject's body size by dividing their height. 31) It incorporates the advantages of both BMI and waisttohip ratio by accounting for height and abdominal adipo sity. 32) Waisttoheight ratio further indicates cardiometabolic risk based on BMI percentile. 33) Furthermore, our study is unique in that we enrolled 12 to 13yearold young adolescents as subjects and measured their Tanner stages to take the hormonal effect into con sideration. Young adolescence, twelve to fourteen years old, is a pivotal stage for constituting healthy lifestyle habits and the majority of the patterns constructed during this expanding period persist well into adulthood. 34) Accordingly, it is of critical signifi cance that pediatricians recognize young adolescents at risk of obesity and/or metabolic abnormalities such as insulin resistance at an early stage of development and adjust their style of living, such as dietary patterns. However, the present research has a few inherent limitations. First, the epidemiological, crosssectional method of this research does not allow for a causal inference. Second, we did not implement ultrasonography on participants with elevated ALT for the diagnosis of NAFLD; however, previous research have reported that the asso ciation between ALT or AST and fatty liver disease is so precise that elevated ALT and/or AST can be used as a surrogate marker for suspected fatty liver. 3, 4, 35) In conclusion, we have demonstrated that higher serum ALT concentrations are found in the presence of overweight/obesity in apparently healthy young adolescents and that serum ALT concen trations are significantly and positively associated with waistto height ratio, systolic BP, and HOMAIR. More intensified clinical screening strategies and interventions are warranted for adolescents at risk, particularly those with abdominal obesity, in order to lower the risk of liver disease at an early stage in young adolescents.
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